Analysis of Factors that Influence Hematopoietic Recovery in Autologous Transplanted Patients with Hematopoietic Stem Cells from Peripheral Blood

BACKGROUND: Successful hematopoietic stem cell transplantation (HSCT) requires a rapid and durable hematopoietic recovery. AIM: The aim of our study was to analyse factors that influence hematopoietic recovery after autologous HSCT. MATERIALS AND METHODS: Multiple regression analysis was used to analyse factors affecting neutrophil and platelet engraftment in 90 autologous transplanted patients – 30 with acute myeloid leukaemia (AML), 30 with lymphoma and 30 with multiple myeloma (MM) from 2008 till 2016. RESULTS: The neutrophil recovery in AML patients was significantly influenced by transfusion support with random-donor platelets, sex and number of transplanted mononuclear cells (MNC) and CD34+ cells; and in lymphoma patients, it was influenced by sex, age, mobilisation strategy and some transplanted MNC. The influence of investigated factors on neutrophil engraftment in MM patients was not statistically significant. The platelet recovery in AML patients was influenced by transfusion support with random-donor platelets; in lymphoma patients, it was influenced by sex, age, time from diagnosis to harvesting and time from diagnosis to HSCT; and in MM patients it was influenced by transfusion support with random-donor platelets. CONCLUSION: Additional studies are necessary to better understanding of engraftment kinetic to improve the safety of HSCT and to minimise potential complications and expenses related to HSCT.

[1]  A. Nademanee,et al.  Engraftment and outcomes following autologous stem cell transplantation in Hodgkin lymphoma patients mobilized with plerixafor , 2017, Hematological oncology.

[2]  Sunil V. Rao,et al.  Clinical Practice Guidelines From the AABB: Red Blood Cell Transfusion Thresholds and Storage. , 2016, JAMA.

[3]  J. Szer,et al.  A Review of Hematopoietic Cell Transplantation in Australia and New Zealand, 2005 to 2013. , 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[4]  S. Crawford,et al.  Indications for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation. , 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[5]  Benjamin Djulbegovic,et al.  Platelet Transfusion: A Clinical Practice Guideline From the AABB , 2015, Annals of Internal Medicine.

[6]  O. Hyrien,et al.  Clinical factors affecting engraftment and transfusion needs in SCT: a single-center retrospective analysis , 2013, Bone Marrow Transplantation.

[7]  B. Johansson,et al.  Autologous hematopoietic stem cell transplantation in multiple myeloma and lymphoma: an analysis of factors influencing stem cell collection and hematological recovery , 2012, Medical Oncology.

[8]  A. Gratwohl,et al.  Changes in the use of hematopoietic stem cell transplantation: a model for diffusion of medical technology , 2010, Haematologica.

[9]  B. Labar,et al.  Collection and composition of autologous peripheral blood stem cells graft in patients with acute myeloid leukemia: influence on hematopoietic recovery and outcome. , 2010, Collegium antropologicum.

[10]  S. Ganguly,et al.  Role of transfusion in stem cell transplantation: a freedom-from-transfusion (FFT), cost and survival analysis , 2010, Journal of medical economics.

[11]  A. Ozet,et al.  Factors affecting engraftment time in autologous peripheral stem cell transplantation. , 2010, Asian Pacific journal of cancer prevention : APJCP.

[12]  D. Benvegnú,et al.  Successful Hematopoietic Stem Cell Transplantation (hsct), Both Autologous and Allogeneic, Requires a Rapid and Durable Engraftment, with Neutrophil (>500/μl) and Platelet (>20,000/ Μl) Reconstitution. Factors Influencing Engraftment after Autolo- Gous or Allogeneic Hsct Were Investigated in 65 Pati , 2022 .

[13]  A. Nademanee,et al.  Peripheral blood hematopoietic stem cell mobilization and collection efficacy is not an independent prognostic factor for autologous stem cell transplantation , 2007, Transfusion.

[14]  J. Armitage,et al.  Autologous Hematopoietic Cell Transplantation for Non‐Hodgkin's Lymphoma , 2007 .

[15]  S. Alshemmari,et al.  Factors influencing engraftment in autologous peripheral stem cell transplantation. The experience of a local Kuwaiti transplantation center. , 2007, Saudi medical journal.

[16]  U. Ergene,et al.  Factors influencing engraftment in autologous peripheral hematopoetic stem cell transplantation (PBSCT). , 2006, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[17]  Mark Ende,et al.  Hematopoietic stem-cell transplantation. , 2006, The New England journal of medicine.

[18]  A. Sempere,et al.  Factors influencing hematopoietic recovery after autologous blood stem cell transplantation in patients with acute myeloblastic leukemia and with non-myeloid malignancies , 2002, Bone Marrow Transplantation.

[19]  N. Schmitz,et al.  Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe , 2002, Bone Marrow Transplantation.

[20]  D. Blaise,et al.  Enhanced activation of B cells in a granulocyte colony‐stimulating factor‐mobilized peripheral blood stem cell graft , 2001, British journal of haematology.

[21]  L. Villalón,et al.  Autologous peripheral blood progenitor cell transplantation with <2 x 10(6) CD34(+)/kg: an analysis of variables concerning mobilisation and engraftment. , 2000, The hematology journal : the official journal of the European Haematology Association.

[22]  M. Offidani,et al.  Factors affecting hemopoietic recovery after high-dose therapy and autologous peripheral blood progenitor cell transplantation: a single center experience. , 1998, Haematologica.

[23]  D. Huhn,et al.  Hematopoietic rescue after high-dose chemotherapy using autologous peripheral-blood progenitor cells or bone marrow: a randomized comparison. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  B. Barlogie,et al.  Peripheral blood stem cell transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patients. , 1995, Blood.

[25]  G. Kandel,et al.  Comparison of hematopoietic and immune recovery after autologous bone marrow or blood stem cell transplants. , 1992, Bone marrow transplantation.